DrugPatentWatch Database Preview
Profile for Canada Patent: 2555291
US Patent Family Members and Approved Drugs for Canada Patent: 2555291
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Try a Free Trial | Mar 28, 2026 | Bristol Myers Squibb | SPRYCEL | dasatinib |
➤ Try a Free Trial | Feb 4, 2025 | Bristol Myers Squibb | SPRYCEL | dasatinib |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |